Weiler J M, Ballas Z K, Feldbush T L, Needleman B W
Immunology. 1982 Jun;46(2):247-52.
Preparations of the third component of human complement (C3) inhibit human lymphocyte blastogenic response to mitogens and antigens when cultured in serum-free medium or in medium supplemented with 5% autologous serum (AS). In contrast, when the culture medium was supplemented with 5% foetal calf serum (FCS), C3 failed to inhibit responses to mitogen (concanavalin A) or to antigen (streptolysin O); some FCS lots allowed stimulation rather than inhibition of the lymphocyte responses. Moreover, when lymphocytes were cultured in serum containing equal amounts of FCS and AS, no inhibition was seen. Our findings may explain previous studies which suggest that C3 enhances or has no effect on lymphocyte responses.
人补体第三成分(C3)制剂在无血清培养基或添加5%自体血清(AS)的培养基中培养时,可抑制人淋巴细胞对有丝分裂原和抗原的增殖反应。相比之下,当培养基中添加5%胎牛血清(FCS)时,C3未能抑制对有丝分裂原(刀豆球蛋白A)或抗原(链球菌溶血素O)的反应;一些FCS批次反而能刺激而非抑制淋巴细胞反应。此外,当淋巴细胞在含有等量FCS和AS的血清中培养时,未观察到抑制作用。我们的研究结果可能解释了先前表明C3可增强淋巴细胞反应或对其无影响的研究。